VITA 34 International AG: VITA 34 presents figures for first quarter 2011

Leipzig, (PresseBox) - .
- Revenue in first quarter increased from 3.5m Euro to 3.7m Euro
- 2,190 storages of umbilical cord blood, EBIT of -0.4m Euro
- Forecast for the total year 2011 confirmed
- Growth accelerated by planned foreign expansion and intensified marketing operations

The VITA 34 International AG (ISIN DE000A0BL849), parent company of the oldest private umbilical cord blood bank in Europe, VITA 34 AG, has increased its revenue in the first quarter 2011 to 3.7m Euro compared to 3.5m Euro in the previous year. The figures also include the subsidiary Secuvita, S. L. The majority of the former Spanish partner was taken over in May 2010 and the shares were increased step by step from initially 51.62 percent to 88 percent in July 2010.

In the first quarter 2011, 2,190 umbilical cord blood preparations were stored, compared to 2,477 storages in the same period last year. The earnings before interest and tax (EBIT) amounted to -0.4m Euro compared to 0.2m Euro and the group result to -0.3m Euro compared to 0.3m Euro.

Because of the variations in births during the period, the first quarter is traditionally the weakest of the entire business year of VITA 34. As regards the total year 2011, VITA 34 is confident to achieve its own forecast and, as already announced, to improve its profitability. A revenue of more than 18m Euro, after 17m Euro in 2010, is still aimed at. For this purpose, the marketing operations are to be further intensified and, as already announced, the foreign business to be expanded. VITA 34 wants to be represented in Slovakia in 2011. In the medium-term, VITA 34 expects positive contributions to the operating income from this region.

The complete quarterly report is available to be downloaded at www.vita34group.com.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.